ALEXZA PHARMACEUTICALS INC | 3,583 Euro | +0,182 +5,35 % | |
| WKN: A1JZW9 ISIN: US0153842093 Ticker-Symbol: N3VN | Frankfurt | 22.05.13 | 16:35 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 15.05. | Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? | 4 | Seeking Alpha | |
| 15.05. | Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning | 17 | Seeking Alpha | |
| 15.05. | Alexza Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript | 1 | Seeking Alpha | |
| 14.05. | Alexza Reports 2013 First Quarter Financial Results | 27 | PR Newswire | |
| MOUNTAIN VIEW, Calif., May 14, 2013 /PRNewswire/ --Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the fiscal quarter March 31, 2013. The net loss for the quarters... Mehr lesen zu: Alexza Reports 2013 First Quarter Financial Results | ||||
| 13.05. | Teva - Alexza Sign Deal for Adasuve | 4 | Zacks | |
| 09.05. | Teva to commercialize Alexza Adasuve (loxapine) inhalation powder in US | 6 | Pharma Bus Review | |
| 08.05. | Alexza cuts deal with Teva on schizophrenia, bipolar treatment | 7 | bizjournals | |
| 08.05. | UPDATE: Teva, Alexza Pharmaceuticals In Inhaler Licensing Pact | 2 | Euroinvestor | |
| 08.05. | Buyers Accumulate Shares of Alexza Pharmaceuticals, Up 43.0% | 1 | SmarTrend | |
| 08.05. | Teva Pharmaceutical, Alexza Pharmaceuticals Reach Licensing Pact for Adasuve | 2 | Euroinvestor | |
| 08.05. | Teva to market Alexza agitation treatment in the U.S. | 2 | Reuters.com | |
| 08.05. | Alexza Announces Conference Call to Discuss Agreement with Teva to Market ADASUVE in the U.S. | 77 | PR Newswire | |
| MOUNTAIN VIEW, Calif., May 8, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) announced today that they have entered into an exclusive U.S. license and supply agreement with Teva... Mehr lesen zu: Alexza Announces Conference Call to Discuss Agreement with Teva to Market ADASUVE in the U.S. | ||||
| 08.05. | Teva and Alexza Announce Teva's License to Market ADASUVE in the U.S. | 17 | PR Newswire | |
| NORTH WALES, Pa. andMOUNTAIN VIEW, Calif., May 8, 2013 /PRNewswire/ --Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA), and Alexza Pharmaceuticals, Inc.... Mehr lesen zu: Teva and Alexza Announce Teva's License to Market ADASUVE in the U.S. | ||||
| 06.05. | Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy | 11 | PR Newswire | |
| MOUNTAIN VIEW, Calif., May 6, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Company has been selected to present its AZ-002 (Staccato® alprazolam) program... Mehr lesen zu: Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy | ||||
| 02.05. | Update: Alexza to Report 2013 First Quarter Financial Results on Tuesday, May 14, 2013 | 39 | PR Newswire | |
| MOUNTAIN VIEW, Calif., May 1, 2013 /PRNewswire/ --Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended March 31, 2013 on Tuesday, May 14, 2013... Mehr lesen zu: Update: Alexza to Report 2013 First Quarter Financial Results on Tuesday, May 14, 2013 | ||||
| 22.04. | Alexza to Report 2013 First Quarter Financial Results on Thursday, May 9, 2013 | 37 | PR Newswire | |
| MOUNTAIN VIEW, Calif., April 22, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended March 31, 2013 on Thursday, May 9, 2013, following... Mehr lesen zu: Alexza to Report 2013 First Quarter Financial Results on Thursday, May 9, 2013 | ||||
| 12.04. | Possible Bearish Inside Day Candle Pattern Detected for Alexza Pharmaceuticals | 1 | SmarTrend | |
| 03.04. | Upgrade Alert for Alexza Pharmaceuticals | 4 | SmarTrend | |
| 27.03. | Alexza Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript | 1 | Seeking Alpha | |
| 26.03. | Alexza Reports 2012 Fourth Quarter and Full Year Financial Results | 47 | PR Newswire | |
| MOUNTAIN VIEW, Calif., March 26, 2013 /PRNewswire/ --Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the fiscal quarter and full year ended December 31, 2012. The... Mehr lesen zu: Alexza Reports 2012 Fourth Quarter and Full Year Financial Results | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| ARENA PHARMACEUTICALS | 6,14 | +0,11 % | Arena Pharmaceuticals - Out To Launch Or Out To Lunch? |
| MAST THERAPEUTICS | 0,50 | -1,19 % | Mast Therapeutics Reports First Quarter 2013 Financial Results |
| SUNESIS PHARMACEUTICALS | 4,299 | -3,18 % | Sunesis Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 12:30 PM |
| DARA BIOSCIENCES | 0,562 | +3,12 % | Can Dara Biosciences bust out of this slump? |
| ARYX THERAPEUTICS | 0,004 | +100 % | XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-013 |
